Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > only 3 calls left now!
View:
Post by Liked2Think on Oct 31, 2022 3:46pm

only 3 calls left now!

all through into next year.

must be down to one "case manager" now and they can only do 3 calls a day.

Yeah this company is nearing break even alright!
Comment by LithLover on Oct 31, 2022 5:17pm
You do realize they have seperate programs one stream for regular Care Oncology calls and than another for the Care Oncology Plus calls.   They are under 2 seperate calendars: https://careoncology.com/reserve-a-call-with-a-case-manager/ https://careoncology.com/reserve-a-call-coc/ Still want to talk about how they aren't growing. 
Comment by Liked2Think on Oct 31, 2022 6:10pm
Great another webpage that makes no sense. Im convinced
Comment by LithLover on Oct 31, 2022 6:39pm
I expect its hard for you to understand so probably why it makes no sense for you. It's OK let me help you:  If you are interested in talking to a case manager about the COC Protocol or Avrt you can book a call thru the online calendar.  (Calendar #1) If you are already in the Care Oncology program or are concerned about your metaboilic health and inflamation you can enter the ...more  
Comment by Nailbiter2 on Oct 31, 2022 7:50pm
This post has been removed in accordance with Community Policy
Comment by Liked2Think on Nov 01, 2022 11:12am
thats all fine and dandy but how does that explain the numbers on the webpages? Now all the days past nov 14 are gone.  Now there are a total of 16 available spots if you add up both spreadsheets per day but before it was 16 days on one webpage, then it was down to 3 on each page. How can anyone trust either one of these webpages at all? random number generator
Comment by Nailbiter2 on Nov 01, 2022 11:56am
This post has been removed in accordance with Community Policy
Comment by Liked2Think on Nov 01, 2022 12:49pm
Your right how could I possible think what they say or present isnt 100% truth 1. Oncore $20M "deal" 2. iBodyCheck deal with Oncore for $60M 3. "$30M in revenue" 4. 1,000 covid tests per day capacity ramping up to 3,000 5. CARE pulls in $1M worth of revenue per quarter 18 months ago, wait how much revenue did the combined CARE/Stage company bring in the last 4 quarters? But ...more  
Comment by Mykndrsn on Nov 01, 2022 12:08pm
Why are you bothering? This board is no longer relevant. I mean just read the posts here, it's pathetic. Give up, many have, myself included. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities